Monsanto Company (MON) Stake Increased by CS Mckee LP
CS Mckee LP grew its holdings in Monsanto Company (NYSE:MON) by 55.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 127,950 shares of the basic materials company’s stock after buying an additional 45,500 shares during the quarter. CS Mckee LP’s holdings in Monsanto were worth $15,144,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of MON. Warren Averett Asset Management LLC acquired a new stake in shares of Monsanto in the 1st quarter valued at approximately $228,000. Fairbanks Capital Management Inc. lifted its holdings in shares of Monsanto by 0.7% in the 1st quarter. Fairbanks Capital Management Inc. now owns 170,151 shares of the basic materials company’s stock valued at $19,261,000 after buying an additional 1,226 shares during the period. Harel Insurance Investments & Financial Services Ltd. lifted its holdings in shares of Monsanto by 167.6% in the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 5,753 shares of the basic materials company’s stock valued at $668,000 after buying an additional 3,603 shares during the period. Virginia Retirement Systems ET AL acquired a new stake in shares of Monsanto in the 1st quarter valued at approximately $17,082,000. Finally, State of Tennessee Treasury Department lifted its holdings in shares of Monsanto by 3.4% in the 1st quarter. State of Tennessee Treasury Department now owns 316,625 shares of the basic materials company’s stock valued at $35,842,000 after buying an additional 10,291 shares during the period. 74.81% of the stock is owned by institutional investors and hedge funds.
MON has been the subject of several recent analyst reports. Zacks Investment Research cut Monsanto from a “buy” rating to a “hold” rating in a report on Tuesday, September 12th. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target for the company in a report on Wednesday, July 12th. UBS AG cut Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 price target for the company. in a report on Friday, August 18th. BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $128.00 price objective (up from $120.00) on shares of Monsanto in a report on Thursday, June 29th. Ten equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $125.45.
In other Monsanto news, VP Duraiswami Narain sold 2,860 shares of the business’s stock in a transaction on Monday, September 25th. The shares were sold at an average price of $120.00, for a total transaction of $343,200.00. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Brett D. Begemann sold 22,640 shares of the business’s stock in a transaction on Monday, September 25th. The shares were sold at an average price of $120.03, for a total transaction of $2,717,479.20. Following the sale, the chief operating officer now directly owns 85,439 shares in the company, valued at $10,255,243.17. The disclosure for this sale can be found here. 0.79% of the stock is owned by insiders.
ILLEGAL ACTIVITY NOTICE: This piece was originally published by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.dailypolitical.com/2017/10/09/monsanto-company-mon-stake-increased-by-cs-mckee-lp.html.
Shares of Monsanto Company (MON) traded up 0.046% during midday trading on Monday, hitting $119.785. The stock had a trading volume of 690,845 shares. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $120.50. The company’s 50-day moving average price is $118.25 and its 200-day moving average price is $117.04. The firm has a market cap of $52.65 billion, a price-to-earnings ratio of 23.538 and a beta of 1.07.
Monsanto (NYSE:MON) last announced its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.41) by $0.61. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The company had revenue of $2.69 billion for the quarter, compared to the consensus estimate of $2.51 billion. During the same period in the previous year, the business earned $0.07 EPS. The company’s revenue was up 4.8% on a year-over-year basis. Equities research analysts forecast that Monsanto Company will post $5.66 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be paid a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a yield of 1.80%. The ex-dividend date is Thursday, October 5th. Monsanto’s dividend payout ratio (DPR) is currently 42.27%.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.